Researchers have developed a simple blood test that measures the body's own immune response to improve diagnosis of ovarian cancer.
The study, published in the journal Scientific Reports, found that testing for a specific immune biomarker allows clinicians to identify whether growths on the ovaries are cancerous or not, without the need for tests like the MRI scans or ultrasounds.


